Randomised Controlled Trial of Interferon Alfa (Lymphoblastoid Interferon) in Chronic Non-A Non-B Hepatitis.

BMJ
doi 10.1136/bmj.298.6666.80
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.

Gut
Gastroenterology
1993English

Efficacy of Consensus Interferon in Treatment of HbeAg-positive Chronic Hepatitis B: A Multicentre, Randomized Controlled Trial

Virology Journal
VirologyInfectious Diseases
2009English

Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

Hepatitis Monthly
HepatologyInfectious Diseases
2013English

A Randomised Placebo Controlled Trial of Pegylated Interferon in Active Ulcerative Colitis

Gut
Gastroenterology
2003English

Interferon and Lamivudine vs. Interferon for Hepatitis B E Antigen-Positive Hepatitis B Treatment: Meta-Analysis of Randomized Controlled Trials

Liver International
Hepatology
2007English

Lack of Efficacy of Low Dose Oral Interferon Alfa in Symptomatic HIV-1 Infection: A Randomised, Double Blind, Placebo Controlled Trial

Sexually Transmitted Infections
DermatologyInfectious Diseases
1998English

A Limit of Current Interferon Therapy for Chronic Hepatitis Type B.

Acta Hepatologica Japonica
Hepatology
1994English

Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.

Gut
Gastroenterology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy